These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 12627514

  • 1. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center.
    Azzola MF, Shaw HM, Thompson JF, Soong SJ, Scolyer RA, Watson GF, Colman MH, Zhang Y.
    Cancer; 2003 Mar 15; 97(6):1488-98. PubMed ID: 12627514
    [Abstract] [Full Text] [Related]

  • 2. The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up.
    Francken AB, Shaw HM, Thompson JF, Soong SJ, Accortt NA, Azzola MF, Scolyer RA, Milton GW, McCarthy WH, Colman MH, McGovern VJ.
    Ann Surg Oncol; 2004 Apr 15; 11(4):426-33. PubMed ID: 15070604
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma.
    Barnhill RL, Katzen J, Spatz A, Fine J, Berwick M.
    J Cutan Pathol; 2005 Apr 15; 32(4):268-73. PubMed ID: 15769275
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Independent prognostic importance of vascular invasion in nodular melanomas.
    Straume O, Akslen LA.
    Cancer; 1996 Sep 15; 78(6):1211-9. PubMed ID: 8826942
    [Abstract] [Full Text] [Related]

  • 7. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
    Marghoob AA, Koenig K, Bittencourt FV, Kopf AW, Bart RS.
    Cancer; 2000 Feb 01; 88(3):589-95. PubMed ID: 10649252
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.
    Svobodová S, Browning J, MacGregor D, Pollara G, Scolyer RA, Murali R, Thompson JF, Deb S, Azad A, Davis ID, Cebon JS.
    Eur J Cancer; 2011 Feb 01; 47(3):460-9. PubMed ID: 21115342
    [Abstract] [Full Text] [Related]

  • 10. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study.
    Barnhill RL, Fine JA, Roush GC, Berwick M.
    Cancer; 1996 Aug 01; 78(3):427-32. PubMed ID: 8697387
    [Abstract] [Full Text] [Related]

  • 11. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.
    Gimotty PA, Van Belle P, Elder DE, Murry T, Montone KT, Xu X, Hotz S, Raines S, Ming ME, Wahl P, Guerry D.
    J Clin Oncol; 2005 Nov 01; 23(31):8048-56. PubMed ID: 16258103
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mitotic rate in melanoma: a reexamination.
    Attis MG, Vollmer RT.
    Am J Clin Pathol; 2007 Mar 01; 127(3):380-4. PubMed ID: 17276944
    [Abstract] [Full Text] [Related]

  • 14. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
    Phan A, Touzet S, Dalle S, Ronger-Savlé S, Balme B, Thomas L.
    Br J Dermatol; 2007 Aug 01; 157(2):311-8. PubMed ID: 17596173
    [Abstract] [Full Text] [Related]

  • 15. Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry.
    Eigentler TK, Buettner PG, Leiter U, Garbe C, Central Malignant Melanoma Registry of the German Dermatological Society.
    J Clin Oncol; 2004 Nov 01; 22(21):4376-83. PubMed ID: 15514379
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
    Crocetti E, Mangone L, Lo Scocco G, Carli P.
    Melanoma Res; 2006 Oct 01; 16(5):429-33. PubMed ID: 17013092
    [Abstract] [Full Text] [Related]

  • 19. Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model.
    Sahin S, Rao B, Kopf AW, Lee E, Rigel DS, Nossa R, Rahman IJ, Wortzel H, Marghoob AA, Bart RS.
    Cancer; 1997 Oct 15; 80(8):1426-31. PubMed ID: 9338466
    [Abstract] [Full Text] [Related]

  • 20. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril MF, Ortiz Romero PL, Robert T, Balacescu O, Eggermont AM, Lenoir G, Sarasin A, Tursz T, van den Oord JJ, Spatz A, Melanoma Group of the European Organization for Research and Treatment of Cancer.
    J Natl Cancer Inst; 2006 Apr 05; 98(7):472-82. PubMed ID: 16595783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.